Dialectic Is A Texas Based Clinical Stage Biotechnology Company Focused On Creating Innovative New Technologies To Treat Cancerour Goal Is To Relieve The Suffering Of Patients With Cancer And Prolong Their Productive Lives Through Targeted Therapies With Limited Toxicities And Complicationsbased In Dallastexasdialectic Has Research Partners And Facilities At Ut Health San Antonio And University Of Florida Health Biotech Venture Investors John Dharkeyjrand Drdavid Genecov Capitalized The Company In 2018 And Are Co Founders Along With Drrobert Hromasdean Of The Long School Of Medicine At Ut Health San Antoniodrdaohong Zhou At University Of Florida Health Cancer Centerand Drguangrong Zheng At University Of Florida College Of Pharmacy
